Pharmacokinetics and Toxicities after Evomela? (Propylene Glycol Free Melphalan) with Hematopoietic Stem Cell Transplant (HCT) for Multiple Myeloma (MM), AL Amyloidosis (AL), Lymphoma, Acute Myeloid Leukemia (AML), and Myelodysplastic Syndrome (MDS)

Gunjan L. Shah; Heather Landau; Caitlin Sarubbi; Ryan Schofield; Andrew Lin; Valkal Bhatt; Stephen Harnicar; Sean M. Devlin; Hugo Castro-Malaspina; David J. Chung; Parastoo B. Dahi; Boglarka Gyurkocza; Guenther Koehne; Matthew J. Matasar; Craig H. Moskowitz; Esperanza B. Papadopoulos; Craig S. Sauter; Brian C. Shaffer; Roni Tamari; Dean Carlow; Sergio A. Giralt

首页> 外文期刊>Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation >Pharmacokinetics and Toxicities after Evomela? (Propylene Glycol Free Melphalan) with Hematopoietic Stem Cell Transplant (HCT) for Multiple Myeloma (MM), AL Amyloidosis (AL), Lymphoma, Acute Myeloid Leukemia (AML), and Myelodysplastic Syndrome (MDS)

【24h】

Pharmacokinetics and Toxicities after Evomela? (Propylene Glycol Free Melphalan) with Hematopoietic Stem Cell Transplant (HCT) for Multiple Myeloma (MM), AL Amyloidosis (AL), Lymphoma, Acute Myeloid Leukemia (AML), and Myelodysplastic Syndrome (MDS)

机译：None

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation》 |2018年第3期|共2页
作者
Gunjan L. Shah; Heather Landau; Caitlin Sarubbi; Ryan Schofield; Andrew Lin; Valkal Bhatt; Stephen Harnicar; Sean M. Devlin; Hugo Castro-Malaspina; David J. Chung; Parastoo B. Dahi; Boglarka Gyurkocza; Guenther Koehne; Matthew J. Matasar; Craig H. Moskowitz; Esperanza B. Papadopoulos; Craig S. Sauter; Brian C. Shaffer; Roni Tamari; Dean Carlow; Sergio A. Giralt;
展开▼
作者单位

Department of Medicine Adult Bone Marrow Transplant Service Memorial Sloan Kettering Cancer Center;

Department of Medicine Adult Bone Marrow Transplant Service Memorial Sloan Kettering Cancer Center;

Department of Medicine Adult Bone Marrow Transplant Service Memorial Sloan Kettering Cancer Center;

Department of Laboratory Medicine Memorial Sloan Kettering Cancer Center;

Department of Pharmacy Memorial Sloan Kettering Cancer Center;

Department of Pharmacy Memorial Sloan Kettering Cancer Center;

Department of Pharmacy Memorial Sloan Kettering Cancer Center;

Department of Medicine Weill Cornell Medical College;

Department of Medicine Adult Bone Marrow Transplant Service Memorial Sloan Kettering Cancer Center;

Department of Medicine Adult Bone Marrow Transplant Service Memorial Sloan Kettering Cancer Center;

Department of Medicine Adult Bone Marrow Transplant Service Memorial Sloan Kettering Cancer Center;

Department of Medicine Adult Bone Marrow Transplant Service Memorial Sloan Kettering Cancer Center;

Department of Medicine Adult Bone Marrow Transplant Service Memorial Sloan Kettering Cancer Center;

Department of Medicine Adult Bone Marrow Transplant Service Memorial Sloan Kettering Cancer Center;

Department of Medicine Adult Bone Marrow Transplant Service Memorial Sloan Kettering Cancer Center;

Department of Medicine Adult Bone Marrow Transplant Service Memorial Sloan Kettering Cancer Center;

Department of Medicine Adult Bone Marrow Transplant Service Memorial Sloan Kettering Cancer Center;

Department of Medicine Adult Bone Marrow Transplant Service Memorial Sloan Kettering Cancer Center;

Department of Medicine Adult Bone Marrow Transplant Service Memorial Sloan Kettering Cancer Center;

Department of Laboratory Medicine Memorial Sloan Kettering Cancer Center;

Department of Medicine Adult Bone Marrow Transplant Service Memorial Sloan Kettering Cancer Center;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
专利

1. Pharmacokinetics and Toxicities after Evomela? (Propylene Glycol Free Melphalan) with Hematopoietic Stem Cell Transplant (HCT) for Multiple Myeloma (MM), AL Amyloidosis (AL), Lymphoma, Acute Myeloid Leukemia (AML), and Myelodysplastic Syndrome (MDS) [J] . Gunjan L. Shah, Heather Landau, Caitlin Sarubbi, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2018,第3期

机译：None
2. Feasibility and Toxicity of Pharmacokinetic (PK)-Directed Dosing of Evomela? (propylene glycol free melphalan, PGF-MEL) for Multiple Myeloma (MM) and AL Amyloidosis (AL) Patients Undergoing Autologous Hematopoietic Stem Cell Transplant (AHCT) [J] . Gunjan L. Shah, Andrew Lin, Ryan Schofield, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2018,第3期

机译：药代动力学（PK）的可行性和毒性 - Evomela的编号剂量？（丙二醇游离Melphalan，PGF-MEL）用于多发性骨髓瘤（mm）和Al淀粉样症（Al）患者接受自体造血干细胞移植（AHCT）
3. Feasibility and Toxicity of Pharmacokinetic (PK)-Directed Dosing of Evomela? (propylene glycol free melphalan, PGF-MEL) for Multiple Myeloma (MM) and AL Amyloidosis (AL) Patients Undergoing Autologous Hematopoietic Stem Cell Transplant (AHCT) [J] . Gunjan L. Shah, Andrew Lin, Ryan Schofield, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2018,第3期

机译：药代动力学（PK）的可行性和毒性 - Evomela的编号剂量？（丙二醇游离Melphalan，PGF-MEL）用于多发性骨髓瘤（mm）和Al淀粉样症（Al）患者接受自体造血干细胞移植（AHCT）
4. Ras gene mutation in acute myeloid leukemia and Myelodysplastic syndromes: a meta-analysis of its occurrence and prognostic relevance [C] . Cheng Jingru, Wang Peng, Zhang Tai, International Conference on Advanced Materials and Computer Science . 2016

机译：RAS基因突变在急性髓性白血病和髓细胞增强综合征中：荟萃分析其发生和预后相关性
5. CD16xCD33 bispecific killer cell engager (BiKE) activates natural killer (NK) cells from myelodysplastic syndrome (MDS) patients against primary MDS and myeloidderived suppressor cell (MDSC) CD33-positive targets. [D] . Gleason, Michelle K. 2014

机译：CD16xCD33双特异性杀伤细胞接合剂（BiKE）激活来自骨髓增生异常综合征（MDS）患者的自然杀伤（NK）细胞，以抵抗原发性MDS和髓样抑制细胞（MDSC）CD33阳性靶标。
6. Characteristics and outcomes of patients with multiple myeloma (MM) who develop therapy (t)-related myelodysplastic syndrome (MDS) t-chronic myelomonocytic leukemia (CMML) or t-acute myeloid leukemia (AML) [O] . Naveen Pemmaraju, Dhaval Shah, Hagop Kantarjian, -1

机译：患有治疗性（t）相关性骨髓增生异常综合症（MDS）t型慢性粒细胞性白血病（CMML）或t型急性髓性白血病（AML）的多发性骨髓瘤（MM）患者的特征和结局
7. Results of a Phase II Study of Propylene Glycol (PG)-Free, Captisol-Enabled Melphalan Conditioning for Autologous Hematopoietic Stem Cell Transplantation (AHCT) in Patients with Multiple Myeloma (MM) [O] . Hari Parameswaran N., Ajitawi Omar, Arce-Lara Carlos, 2015

机译：多发性骨髓瘤（MM）患者自体造血干细胞移植（AHCT）的无丙二醇（PG），Capcapsol启用Melphalan调理的II期研究结果

Pharmacokinetics and Toxicities after Evomela? (Propylene Glycol Free Melphalan) with Hematopoietic Stem Cell Transplant (HCT) for Multiple Myeloma (MM), AL Amyloidosis (AL), Lymphoma, Acute Myeloid Leukemia (AML), and Myelodysplastic Syndrome (MDS)

著录项

相似文献

相关主题

期刊订阅